Design Therapeutics, Inc. (DSGN) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts DSGN Hot Sheet
Join SI Premium – FREE
Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q4 EPS of ($0.24), $0.02 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q2 EPS by 6c, Offers Guidance
- Bok Financial Corp (BOKF) Tops Q2 EPS by 26c
- Investar Holding (ISTR) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
